Zhengye Biotechnology Holding (ZYBT) Invested Capital (2023 - 2025)
Historic Invested Capital for Zhengye Biotechnology Holding (ZYBT) over the last 3 years, with Q2 2025 value amounting to $50.5 million.
- Zhengye Biotechnology Holding's Invested Capital changed N/A to $50.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $50.5 million, marking a year-over-year change of. This contributed to the annual value of $50.1 million for FY2024, which is 1558.7% down from last year.
- Latest data reveals that Zhengye Biotechnology Holding reported Invested Capital of $50.5 million as of Q2 2025.
- In the past 5 years, Zhengye Biotechnology Holding's Invested Capital ranged from a high of $58.2 million in Q4 2023 and a low of $50.1 million during Q4 2024
- Over the past 3 years, Zhengye Biotechnology Holding's median Invested Capital value was $50.5 million (recorded in 2025), while the average stood at $52.9 million.
- Within the past 5 years, the most significant YoY rise in Zhengye Biotechnology Holding's Invested Capital was 1396.97% (2024), while the steepest drop was 1396.97% (2024).
- Over the past 3 years, Zhengye Biotechnology Holding's Invested Capital (Quarter) stood at $58.2 million in 2023, then decreased by 13.97% to $50.1 million in 2024, then grew by 0.84% to $50.5 million in 2025.
- Its Invested Capital was $50.5 million in Q2 2025, compared to $50.1 million in Q4 2024 and $58.2 million in Q4 2023.